Diagnostic tests are necessary medical procedures employed to detect and diagnose diseases, pivotal in disease control, surveillance, and prevention. They contribute to improved patient care, consumer safety, and optimize healthcare spending. A diagnostic test is used to identify the underlying cause of a condition, whether as part of a medical examination to determine a disease or to elucidate the origin of symptoms. Furthermore, diagnostic tests offer insights into specific strengths and weaknesses when employed for other purposes.
According to Data Bridge Market Research the Diagnostic Tests Market accounted for USD 1,57,104.45 million in 2022, and expected to reach USD 3,24,714.32 million by 2030. The market is expected to grow with a CAGR of 9.5% in the forecast period of 2023 to 2030.
“Growing incidences of infectious and chronic diseases”
The North America population is facing increasing challenges due to the burden of infectious diseases and chronic conditions. Microorganism-caused infectious diseases like diphtheria, ebola, flu, hepatitis, HIV/AIDS, HPV, and tuberculosis, along with sudden outbreaks such as dengue, Zika virus, COVID-19, and Swine flu, are driving the international need for clinical diagnostic tests. The rising prevalence of chronic diseases like cancer, diabetes, cardiovascular disease, obesity, and others is fuelling the demand for clinical diagnostics.
What restraints the growth of the diagnostic tests market?
“Affordability for diagnostics tests”
Affordability for diagnostic tests refers to the ability of individuals to access and afford necessary medical tests. It encompasses factors such as the cost of tests, insurance coverage, out-of-pocket expenses, and financial assistance programs. Ensuring affordability is crucial as it enables equitable access to healthcare services and promotes early detection and timely treatment of diseases. Improving affordability for diagnostic tests involves addressing pricing structures, reducing financial barriers, and implementing policies to make essential tests more accessible and affordable to all individuals. Thus, affordability for diagnostic tests hampers the market.
Segmentation: North America Diagnostic Tests Market
The diagnostic tests market is segmented on the basis of type, solution, technology, mode of testing, approach, sample type, application, testing type, age, end user and distribution channel.
- On the basis of type, the diagnostic tests market is segmented into glucose test, infectious diseases test, cytology test, CBC test, blood culture test, syphilis test, urea test, C-reactive protein test, antigen test, hba1c test, pregnancy test, lipid profile test, electrolytes test, liver function test, stool helicobacter pylori test, calcium test, crossmatch test, thyroid function test, stool microscopy test, urine microscopy test, unit Packed RBCS, test, ESR test and others test.
- On the basis of solution, the diagnostic tests market is segmented into services and products.
- On the basis of technology, the diagnostic tests market is segmented into immunoassay-based, pcr-based, next gene sequencing, spectroscopy-based, chromatography-based, microfluidics, substrate technology and others.
- On the basis of mode of testing, the diagnostic tests market is segmented into prescription-based testing and otc testing.
- On the basis of approach, the diagnostic tests market is segmented into molecular diagnostic instrument, in-vitro diagnostic instrument and point of care testing instrument.
- On the basis of sample type, the diagnostic tests market is segmented into urine, saliva, blood, hair, sweat and others.
- On the basis of application, the diagnostic tests market is segmented into cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, odontology and others.
- On the basis of testing type, the diagnostic tests market is segmented into biochemistry, haematology, microbiology, histopathology and others.
- On the basis of age, the diagnostic tests market is segmented into pediatric, adult and geriatric.
- On the basis of end user, the diagnostic tests market is segmented into hospitals, diagnostic center, research labs and institutes, research institute, homecare, blood banks, specialty clinics, ambulatory surgical centers and others.
- On the basis of distribution channel, the diagnostic tests market is segmented into direct tenders, retail sales and online sales.
Regional Insights: U.S. Dominates the Diagnostic Tests Market
In North America, the U.S. is dominating the market due to the growing adoption of diagnostic tests for preclinical research has contributed to the affordability of such tests in the market. Increased usage of these tests in early-stage research allows for cost-effective identification and validation of potential diagnostic markers, making them more accessible for more comprehensive clinical application.
To know more about the study visit, https://www.databridgemarketresearch.com/es/reports/north-america-diagnostic-tests-market
Recent Developments
- In 2020, Siemens Healthcare GmbH officially announced the release of the RAPIDPoint 500e Blood Gas Analyzer, which broadened the company's product portfolio and is also used in COVID-19 efforts. This helps to increase revenue from the line.
- In 2020, Siemens Healthcare GmbH and the Marienhaus Hospital Group announced a ten-year collaboration. This collaboration will benefit the company in diagnostics in the long run. This agreement will also help the company's financial situation.
The Prominent Key Players Operating in the Diagnostic Tests Market Include:
- F-Hoffman La-Roche Ltd. (Switzerland)
- ABBOTT (U.S.)
- Danaher (U.S.)
- B.D. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- ACON Laboratories Inc. (U.S.)
- Hemosure, Inc. (U.S.)
- MicroGen Diagnostics (U.S.)
- QIAGEN (Germany)
- Grifols, S.A (Spain)
- BODITECH MED INC. (South Korea)
- Chembio Diagnostic Systems, Inc. (U.S.)
- Nanoentek (South Korea)
- DiaSorin S.p.A. (Italy)
- Bio-Rad Laboratories, Inc. (U.S.)
- BIOMEDOMICS INC (U.S.)
- EKF Diagnostics Holdings plc (U.K.)
- Siemens Healthcare GmbH (Germany)
- PerkinElmer Inc. (U.S.)
- BIOMÉRIEUX (France)
- ARKRAY USA, Inc. (U.S.)
- Biohit Oyj (Finland)
- Germaine Laboratories, Inc. (U.S.)
- Quidel Corporation (U.S.)
- Illumina, Inc. (U.S.)
- Lamdagen Corporation (U.S.)
- LifeSign LLC. (U.S.)
- Medixbiochemica (Finland)
- Nova Biomedical (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Sannuo Biosensing Co., Ltd. (U.S.)
- STRECK (U.S.)
- Sysmex Corporation (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of diagnostic tests market companies contact, https://www.databridgemarketresearch.com/es/contact
Research Methodology: North America Diagnostic Tests Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, North America vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
